Xcout Intel
Hubble Therapeutics, LLC competitors & alternatives
The 12 closest competitors and alternatives to Hubble Therapeutics, LLC among biotechnology companies — ranked by similarity to what Hubble Therapeutics, LLC actually does, not by market-cap band.
Subscribe to see Hubble Therapeutics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Hubble Therapeutics, LLC
Hubble Therapeutics is a patient-focused biotechnology company based in New Hampshire that advances gene therapy to treat LCA16, a rare form of childhood blindness.
Hubble Therapeutics, LLC at a glance
Hubble Therapeutics, LLC is a biotechnology company headquartered in United States. It has raised at least $17.1M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $7.3M in March 2025. Xcout tracks 5 named people at Hubble Therapeutics, LLC, including Jeff Sabados (Chief Executive Officer).
Hubble Therapeutics, LLC leadership
- Jeff SabadosChief Executive Officer
- Bikash Pattnaikscientific co-founder
- Jeff SabadosExecutive Officer
- Greg KeenanDirector
- Sam GoldbergerDirector
Hubble Therapeutics, LLC funding rounds
At least $17.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $7.3M | 1 named | |
| SEC Form D filing | $9.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Hubble Therapeutics, LLC competitors
Ranked by semantic similarity — how close each company is to Hubble Therapeutics, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Similar biotechnology company
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Similar biotechnology company
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Similar biotechnology company
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Similar biotechnology company
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Biotech
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Similar biotechnology company
Homology Medicines, Inc. is a clinical-stage genetic medicines company historically focused on transforming the lives of patients with rare diseases through genetic treatments.
Similar biotechnology company
Hunterian Medicine LLC is a gene-editing company that develops CRISPR-based therapeutics to cure genetic diseases. The company utilizes a patented platform technology with a bidirectional promoter to enable efficient, on-target delivery of CRISPR via a single adeno-associated virus (AAV).
Similar biotechnology company
Kelonia Therapeutics, Inc. is a clinical-stage biotech company headquartered in Boston, Massachusetts, focused on delivering genetic medicine for patients.
Similar biotechnology company
Skylark Bio is a biotechnology company developing precision-targeted, locally delivered gene therapies to treat genetic hearing loss and other single-gene disorders. The company's platform aims to restore natural biological processes and hearing function, addressing conditions that affect children and individuals with genetic communication impairments.
Similar biotechnology company
Rinascera Therapeutics, Inc. is a clinical-stage biotechnology company located in Boston, Massachusetts, dedicated to transforming the treatment of rare genetic skin diseases.
Biotech
Character Biosciences is a biotechnology company that uses human genetics and functional genomics to discover and develop precision medicines. Its work has focused particularly on genetically informed therapies for age-related diseases, including ophthalmic conditions such as age-related macular degeneration.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Hubble Therapeutics, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Hubble Therapeutics, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →